-46.8%
APLD vs GSK
+14.2%
-61.0%
-71.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.5% | +2.4% | +5.1% | +8.7% |
| 7D | +3.1% | +4.9% | -1.8% | +5.7% |
| 30D | -29.4% | +10.8% | -40.2% | -25.6% |
| 3M | -42.8% | -1.8% | -41.0% | -41.9% |
| 6M | -59.5% | +4.1% | -63.6% | -58.1% |
| YTD | -31.8% | +7.9% | -39.7% | -19.5% |
| All | -46.8% | +14.2% | -61.0% | -33.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling